Rosemead, CA, United States of America

Thomas S Dobashi


Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 91(Granted Patents)


Company Filing History:


Years Active: 1995-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Thomas S. Dobashi

Introduction

Thomas S. Dobashi is a notable inventor based in Rosemead, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel methods and compounds for nucleotide sequencing and immunoassays. With a total of 3 patents, his work has advanced the capabilities of molecular biology techniques.

Latest Patents

One of his latest patents is titled "Cyanine dye activating group with improved coupling selectivity." This invention discloses activating groups for cyanine dyes that are used to label chain terminators in nucleotide sequencing. The activating groups, based on N-hydroxyphthalimide, allow for a much higher yield and greater selectivity for the mono-substituted product compared to prior art. Another significant patent is the "Method for making a preconjugate," which involves a process for creating a preconjugate that includes immunogenic species of a polymorphic analyte. This method enhances the efficiency of developing immunoreactive conjugates useful in competitive inhibition immunoassays.

Career Highlights

Thomas S. Dobashi is currently associated with Beckman Instruments, Inc., where he continues to innovate and contribute to advancements in biotechnology. His work has been instrumental in improving the accuracy and efficiency of various analytical techniques.

Collaborations

Throughout his career, Dobashi has collaborated with esteemed colleagues, including Anthony K. Cheng and Gene G-y Shen. These collaborations have further enriched his research and development efforts.

Conclusion

Thomas S. Dobashi's contributions to the field of biotechnology through his patents and collaborations have significantly impacted molecular biology techniques. His innovative approaches continue to pave the way for advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…